11
I
44 patients NSCLC
I
61.2-64.8 Gy (1.8 Gy BID)
I
median FU: 16 months
I
Isolated nodal recurrence:
1 patient (2.3%)
I
88 patients NSCLC
I
dose-escalation study
I
median FU: 16 months
I
Isolated nodal recurrence:
2 patients (2.3%)
De Ruysscher
et al
., IJROBP 2005
Belderbos
et al
., IJROBP 2006
Selective nodal irradiation based on
PET-CT
is safe in NSCLC
Selective nodal irradiation in NSCLC:
FDG-PET-CT based!